Skip to main content
. 2020 Aug 24;23(3):400–411. doi: 10.1093/neuonc/noaa188

Fig. 6.

Fig. 6

Graphical summary. EGFR and DRD2 signaling converge at ERK. Thus, EGFR hyperactivation compensates for DRD2 inhibition.